ADIM
SPTN

Alpha DNA Investment Management’s SpartanNash SPTN Stock Holding History

Alpha DNA Investment Management’s Portfolio SPTN Stock Details SPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-154
Closed -$2K – 770
2020
Q4 		$2K Buy
+154
New +$2.87K ﹤0.01% 485

Other funds holding SPTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Alpha DNA Investment Management's SPTN Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of SpartanNash (SPTN) in Q1 2021, closing a stake of 154 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in SPTN in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 189 funds tracked by Wall St. Rank hold SPTN as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining SpartanNash position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 154 SpartanNash shares in Q1 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in SpartanNash in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's SpartanNash position peaked at $2K in Q4 2020.
  • 189 funds tracked by Wall St. Rank held SpartanNash as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.